Pulsed moxifloxacin for the prevention of exacerbations of chronic obstructive pulmonary disease: a randomized controlled trial
Open Access
- 28 January 2010
- journal article
- research article
- Published by Springer Science and Business Media LLC in Respiratory Research
- Vol. 11 (1), 10
- https://doi.org/10.1186/1465-9921-11-10
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Efficacy of moxifloxacin in the treatment of bronchial colonisation in COPDEuropean Respiratory Journal, 2009
- Infection in the Pathogenesis and Course of Chronic Obstructive Pulmonary DiseaseNew England Journal of Medicine, 2008
- Patient adherence in COPDThorax, 2008
- Effect of Pharmacotherapy on Rate of Decline of Lung Function in Chronic Obstructive Pulmonary DiseaseAmerican Journal of Respiratory and Critical Care Medicine, 2008
- Bronchoscopic validation of the significance of sputum purulence in severe exacerbations of chronic obstructive pulmonary diseaseThorax, 2007
- Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomised controlled trialThe Lancet, 2003
- Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary diseaseThorax, 2002
- New Strains of Bacteria and Exacerbations of Chronic Obstructive Pulmonary DiseaseNew England Journal of Medicine, 2002
- A long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary diseaseEuropean Respiratory Journal, 2002
- Relation of sputum inflammatory markers to symptoms and lung function changes in COPD exacerbationsThorax, 2000